NEWS
CARDINAL HEALTH EXPANDS HOME DIABETES CARE WITH ADSG ACQUISITION
Cardinal Health at-Home Solutions has strengthened its position in the US home healthcare market with the acquisition of Advanced Diabetes Supply Group( ADSG) and its brands, Advanced Diabetes Supply and US MED.
Completed on April 1, 2025, the deal combines ADSG’ s focus on diabetes management with Edgepark’ s broader medical supply portfolio, expanding reach to more patients and enhancing access through pharmacy channels. The integration aims to improve service capabilities for people managing diabetes and associated chronic conditions at home. this with commercial plan access and products across diabetes, ostomy and urology.
“ Acquiring ADSG represented a strategic step forward for at- Home Solutions, particularly in the direct-to-patient provider side of our business,” said Rob Schlissberg, President, Cardinal Health at-Home Solutions.“ The complementary strengths that ADSG brings to this business will further broaden our impact and position us to lead with even greater scale and efficiency than ever before.”
Anthony Alvarez, Senior Vice President and General Manager for ADSG and Edgepark, said:“ When someone living with diabetes needs their supplies, our top priority is making sure those supplies are on their doorstep when they need them to be. ADSG’ s highly accredited customer service model and specialised support expertise are renowned among healthcare providers and those they care for.”
ADSG specialises in delivering continuous glucose monitors, insulin and related supplies directly to patients, with a service model recognised for its customer support and strong performance in Medicare markets. Edgepark complements
WEIGHT LOSS BEFORE IVF INCREASES CHANCE OF NATURAL CONCEPTION BY NEARLY HALF
Women with obesity who take part in weight loss programmes before beginning in vitro fertilisation( IVF) are 47 % more likely to conceive naturally than those given little or no weight loss support, according to the largest review of evidence to date.
The University of Oxford-led study, funded by the National Institute for Health and Care Research, analysed 12 international trials involving 1,921 women. It found that structured weight loss interventions also raised the likelihood of any pregnancy – natural or via IVF – by 21 %.
The findings, published in Annals of Internal Medicine, come as many NHS commissioning bodies restrict access to funded IVF for women with a Body Mass Index above 30. Researchers say structured programmes could improve eligibility and help some women avoid IVF altogether.
Dr Moscho Michalopoulou, Lead Author from Oxford’ s
Nuffield Department of Primary Care Health Sciences, said:“ Our findings offer hope. They suggest that offering structured weight loss support could improve the chance of conceiving naturally, which may avoid the need for IVF treatment.”
The review included diet and exercise plans, as well as medications such as orlistat and early GLP-1 agonists. On average, women in intervention groups lost 4kg more than those in comparison groups.
Researchers called for larger trials following pregnancies through to birth to determine which programmes work best and for whom.
www. intelligenthealth. tech 11